Revolution Medicines, Inc.RVMDNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-913.73M
↓ 241% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-267.88M
Historical baseline
PeriodValueYoY Change
2025$-913.73M-60.9%
2024$-567.74M-58.5%
2023$-358.30M-52.3%
2022$-235.22M-53.0%
2021$-153.71M-49.2%
2020$-103.00M-97.3%
2019$-52.20M-18153.5%
2018$-286000.00+98.9%
2017$-26.72M-